Universal-Beteiligungs- und Servicegesellschaft’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.64M Buy
264,638
+5,451
+2% +$172K 0.01% 669
2026
Q1
$7.26M Buy
259,187
+24,292
+10% +$797K 0.01% 726
2025
Q4
$8.79M Buy
234,895
+116
+0% +$3.81K 0.01% 657
2025
Q3
$6.47M Buy
234,779
+66,236
+39% +$2.28M 0.01% 761
2025
Q2
$5.33M Buy
168,543
+15,217
+10% +$490K 0.01% 811
2025
Q1
$5.09M Buy
153,326
+59,315
+63% +$2.13M 0.01% 794
2024
Q4
$3.23M Buy
+94,011
New +$3.23M 0.01% 817

Other funds holding HRMY

Universal-Beteiligungs- und Servicegesellschaft's HRMY Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Harmony Biosciences (HRMY) stake by 2.1% in Q2 2026, buying an estimated $172K and bringing the position to 264,638 shares worth $9.64M. The position accounts for 0.01% of the portfolio, ranked #669.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 264,638 shares of Harmony Biosciences worth $9.64M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 5,451 Harmony Biosciences shares in Q2 2026, an estimated $172K.
  • Harmony Biosciences made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #669 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.